| Income Statement |
| Total Revenue | 38.68M |
|
| Revenues (USD) | 38.68M |
| Cost of Revenue | 23.56M |
| Gross Profit | 15.12M |
| Operating Expenses | 20.22M |
| Research and Development Expense | 6.15M |
| Selling, General and Administrative Expense | 14.07M |
| Operating Income | -5.09M |
| Interest Expense | 99.00K |
| Income Tax Expense | 40.00K |
| Net Income | -4.45M |
| Net Income Common Stock | -4.45M |
| Net Income Common Stock (USD) | -4.45M |
| Consolidated Income | -4.45M |
| Earnings per Basic Share | -0.02 |
| Earnings per Basic Share (USD) | -0.02 |
| Earnings per Diluted Share | -0.02 |
| Earning Before Interest & Taxes (EBIT) | -4.31M |
| Earning Before Interest & Taxes (USD) | -4.31M |
| Weighted Average Shares | 191.65M |
| Weighted Average Shares Diluted | 191.65M |
| Balance Sheet |
| Cash and Equivalents | 98.82M |
| Cash and Equivalents (USD) | 98.82M |
| Trade and Non-Trade Receivables | 36.75M |
| Current Assets | 168.57M |
| Property, Plant & Equipment Net | 4.86M |
| Total Assets | 300.24M |
| Current Liabilities | 42.72M |
| Total Liabilities | 69.56M |
| Accumulated Retained Earnings (Deficit) | -417.74M |
| Accumulated Other Comprehensive Income | -104.00K |
| Shareholders Equity | 230.67M |
| Shareholders Equity (USD) | 230.67M |
| Assets Non-Current | 131.66M |
| Deferred Revenue | 46.29M |
| Goodwill and Intangible Assets | 110.87M |
| Inventory | 24.40M |
| Liabilities Non-Current | 26.84M |
| Trade and Non-Trade Payables | 8.55M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 2.33M |
| Net Cash Flow from Financing | 393.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.73M |
| Capital Expenditure | -1.09M |
| Issuance (Purchase) of Equity Shares | 952.00K |
| Net Cash Flow from Investing | -1.09M |
| Net Cash Flow from Operations | -4.54M |
| Effect of Exchange Rate Changes on Cash | -491.00K |
| Share Based Compensation | 3.06M |